TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
RexCell Tissue & Airlaid AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,349,015
|
1,478,401
|
1,234,694 |
| Financial expenses |
828
|
837
|
475 |
| Earnings before taxes |
305,077
|
425,773
|
225,578 |
| EBITDA |
318,698
|
442,233
|
252,989 |
| Total assets |
638,027
|
609,364
|
634,639 |
| Current assets |
324,989
|
329,982
|
378,714 |
| Current liabilities |
249,042
|
228,715
|
268,975 |
| Equity capital |
323,635
|
316,192
|
304,118 |
| - share capital |
1,238
|
1,216
|
1,135 |
| Employees (average) |
196
|
200
|
194 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
50.7%
|
51.9%
|
47.9% |
| Turnover per employee |
6,883
|
7,392
|
6,364 |
| Profit as a percentage of turnover |
22.6%
|
28.8%
|
18.3% |
| Return on assets (ROA) |
47.9%
|
70.0%
|
35.6% |
| Current ratio |
130.5%
|
144.3%
|
140.8% |
| Return on equity (ROE) |
94.3%
|
134.7%
|
74.2% |
| Change turnover |
-156,044
|
156,097
|
444,114 |
| Change turnover % |
-10%
|
12%
|
56% |
| Chg. No. of employees |
-4
|
6
|
4 |
| Chg. No. of employees % |
-2%
|
3%
|
2% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.